An international research team, led by Justus Liebig University Giessen (JLU), the Institute for Lung Health (ILH) in Giessen ...

Months, sometimes years, after receiving a clean bill of health, cancer survivors may experience recurrences of the dreaded disease at a different location in the body. Scientists at Mount Sinai have ...

Scientists at Pune's Agharkar Research Institute developed a nanomedicine targeting breast cancer cells by silencing key ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

DAVIS, Calif. (NewsNation) — Scientists at UC Davis in California say they have identified a “switch” that can activate the death of cancer cells — potentially paving the way for new cancer treatment.

Discover how Daraxonrasib is revolutionizing pancreatic cancer treatment, offering new hope where none existed. This ...

At ASCO, Dr Shubham Pant discussed trial results showing Daraxonrasib improved outcomes in advanced pancreatic cancer. He ...

Cancer cells often grow in environments that are low in nutrients, and they cope with this challenge by switching their metabolism to using proteins as alternative 'food'. Building on genetic screens, ...